Cardiovascular Business Week

Susan Hasty, Publisher

Table of Contents . . . September 14th, 2010

Non-Subscriber - Summaries Only

Heart Attack - Comparable Efficacy, Improved Safety and Lower Cost for High-Dose Bolus Dosing of AGGRASTAT(R) Compared to ReoPro(R) in STEMI Patients Undergoing Primary PCI: Three-Year Foll

Emerging Healthcare Solutions, Inc. - EHSI: MedAnywhere Breakthrough Medical iPhone App Module Proceeds to Final Testing Phase

Business News - Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Lymphoma - Epigenetics Therapeutics to 2017 High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma

Major Depressive Disorders - European Commission Issues Positive Decision for Approval of Seroquel XR as an Add-On Treatment of Major Depressive Disorder

Return to Top of Page

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

Search our medical news database

Cardiovascular Business Week

NewsRx is Social

Top Medical Newsletters

Awards

Facts & Stats